Published in Blood Weekly, September 20th, 2001
"Nitric oxide (NO) has been implicated as one of the mediators of acute graft-versus-host disease (GVHD) but reports on its measurement during haemopoietic stem cell transplantation (HSCT) in human are scarce," according to Prof. Raymond Liang and colleagues at Queen Mary Hospital and the University of Hong Kong.
After taking and evaluating such measurements from stem cell recipients, Liang and coworkers found that elevated levels of NO byproducts were a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.